Integrated Proteins Limited Receives BSE Trading Approval for Warrant Conversion
Integrated Proteins Limited has successfully obtained BSE trading approval for 1.55 crore equity shares issued through warrant conversion on a preferential basis to non-promoters at ₹11.25 per share. The approval became effective on December 18, 2025, completing the warrant conversion process that was initially considered by the board in August 2025, resulting in expansion of the company's equity base.